Back
MaxCyte 10K Form
Sell
17
MXCT
MaxCyte
Last Price:
3.42
Seasonality Move:
-8.13%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MXCT News And Ratings
See the #1 stock for the next 7 days that we like better than MXCT
MXCT Financial Statistics
Sales & Book Value
| Annual Sales: | $41.29M |
|---|---|
| Cash Flow: | $-4.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.03 |
| Price / Book: | 1.7 |
Profitability
| EPS (TTM): | -0.34000 |
|---|---|
| Net Income (TTM): | $-35.74M |
| Gross Margin: | $36.55M |
| Return on Equity: | -15.86% |
| Return on Assets: | -13.82% |
MaxCyte Earnings Forecast
Key MaxCyte Financial Ratios
- The Gross Profit Margin over the past 12 years for MXCT is 88.51%.
- The Selling, General & Administrative Expenses for MXCT have been equal to 138.16% of Gross Profit Margin.
- The Research & Development expenses have been 57.69% of Revenue.
- The Interest Expense is -0.54% of Operating Income.
- The Net Earning history of MXCT is -91.85% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 4 years.
MaxCyte Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | MXCT |
| Website: | maxcyte.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.81 |
| Quick Ratio: | 8.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |